The Medical Tubing Market’s Winning Formula: Materials, Precision and Compliance

From IV lines and dialysis circuits to catheters and insulin pumps, medical tubing quietly sits inside a huge share of modern healthcare devices. As procedures become less invasive and treatment moves closer to the patient's home, demand for flexible, biocompatible and precisely engineered tubing keeps climbing. Here is a look at where the market stands, where it is headed, and who is shaping it.

Market Overview & Projections

According to Grand View Research, the global medical tubing market was valued at USD 12.9 billion in 2025 and is estimated at USD 13.9 billion in 2026. It is projected to reach USD 25.5 billion by 2033, expanding at a CAGR of 9.0% from 2026 to 2033.

Several forces are behind this trajectory:

• Minimally invasive procedures: Catheters, guidewires and fluid-management systems all depend on thin-walled, flexible and biocompatible tubing.
• Chronic disease and ageing populations: Long-term care such as dialysis, cardiovascular intervention and respiratory therapy relies heavily on specialised tubing.
• Rising surgical volumes: Surgery counts in OECD countries run into the hundreds of millions each year, lifting consumption of tubing in infusion, drainage and catheter products.
• Medical metal tubing: Stainless steel and other medical-grade metal tubes are widely used in needles, guidewires, surgical instruments and catheter reinforcement, and are gaining ground as robotic and precision surgery platforms expand.

Segment and regional highlights

• By product: Polyvinyl chloride (PVC) led in 2025 with a 30.5% revenue share, thanks to its low cost, flexibility, transparency and compatibility with sterilisation. Fluoropolymers are the fastest-growing material, valued for chemical resistance, thermal stability and low friction in catheter liners and drug delivery devices.
• By application: Bulk disposable tubing held the biggest share at 34.1% in 2025, driven by single-use IV therapy, dialysis, transfusion and fluid management. Drug delivery systems are growing fastest, supported by infusion systems, insulin pumps and home-based treatment devices.
• By region: North America dominated with a 35.3% share in 2025, backed by strong healthcare infrastructure and a deep device manufacturing base, with the U.S. leading the region. Asia Pacific is the fastest-growing region, fuelled by expanding healthcare infrastructure, local device manufacturing and rising healthcare spending in China, India and Japan. Europe remains a significant market, anchored by Germany, France and the UK.

Want to see how the data is structured before you decide? Download Free Sample

Competitive Dynamics & Corporate Landscape

The market is moderately consolidated. A handful of global component manufacturers compete alongside many regional and specialised tubing producers. Success tends to depend less on price and more on a few capabilities:

• Material innovation: Developing silicone, fluoropolymer and multi-lumen tubing for demanding minimally invasive and drug delivery applications.
• Precision manufacturing: Tight-tolerance extrusion, micro-tubing and cleanroom production are table stakes for device OEMs.
• Regulatory compliance: Biocompatibility testing under ISO 10993, GMP requirements and oversight from bodies such as the FDA and EMA create a real barrier to entry for newcomers.
• Customisation and partnerships: Dimensions, wall thickness, flexibility and lumen design are usually tailored to each OEM's device, which encourages long-term supply relationships.

Companies are also growing through acquisitions, product innovation and investment in cleanroom and extrusion capacity. Recent moves illustrate the pattern. In September 2025, Junkosha showcased an expanded portfolio including optically clear peelable heat shrink tubing for catheter manufacturing, after raising production capacity roughly threefold between 2021 and 2025. In April 2025, DuPont introduced Liveo Pharma TPE ultra-low temperature tubing for biopharma processing, a sterilisable, weldable, phthalate-free option rated for conditions down to -86°C and made in ISO Class 7 cleanrooms.

Have questions about the numbers or want a view tailored to your business? Speak to Analyst

Prominent Industry Players

Grand View Research profiles the following companies in its study of the medical tubing market:

• Asahi Tec Corp.
• MDC Industries
• Nordson Corp.
• ZARYS International Group
• Hitachi Cable America, Inc.
• NewAge Industries, Inc.
• TE Connectivity
• Freudenberg & Co. KG
• Spectrum Plastics Group
• ATAG SpA

What It Means for Stakeholders

For device makers, the shift toward fluoropolymers, silicone and multi-lumen designs signals where specification work is heading. For suppliers, capacity in cleanroom extrusion and regulatory depth are likely to separate winners from the rest. For investors, Asia Pacific's momentum and the rapid growth of drug delivery applications point to the most dynamic pockets of demand through 2033.

Go Deeper

The full report covers 2026-2033 forecasts across five regions and 18 countries, with company profiles and competitive analysis.

Explore our dedicated business services:

Prism AI: Market Intelligence with Cited Research- Ask questions in plain language and get insights drawn from Grand View Research's entire research library, with sources cited. Create your free account today.

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today